Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: Protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials
McQuilten, Z., Heritier, S., Fox, L., Fox, V., Young, L., Blombery, P., Cunningham, I., Curnow, J., Higgins, A., Hiwase, D. K., Filshie, R., Firkin, F., Lacaze, P., Mason, K., Mills, A. K., Pepperell, D., Patil, S., Stevenson, W., Szer, J., Waters, N., & 3 others, 18 Jan 2024, In: BMJ open. 14, 1, e076246.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation
Hong, L. E., Wechalekar, M. D., Kutyna, M., Small, A., Lim, K., Thompson-Peach, C., Li, J. J., Chhetri, R., Scott, H. S., Brown, A., Hahn, C. N., Yeung, D. T., Sajid, S., Robinson, N., Thomas, R., Branford, S., D'Andrea, R. J., Samaraweera, S. E., Patnaik, M., Proudman, S., & 4 others, 2024, (Accepted/In press) In: Blood.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Special Issue “Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms”
Kok, C. H., Yeung, D. T. & Hiwase, D. K., Feb 2024, In: International Journal of Molecular Sciences. 25, 4, 2056.Research output: Contribution to journal › Editorial › peer-review
Open Access